Personal information

Other IDs

Scopus Author ID: 56659511100

Activities

Collapse all

Works (50 of 68)

Items per page:
Page 1 of 2

STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma

Future Oncology
2025-03-16 | Journal article
DOI: 10.1080/14796694.2025.2458395
Contributors: Sumanta K. Pal; Thomas Powles; Ravindran Kanesvaran; Javier Molina-Cerrillo; Darren R. Feldman; Pedro Barata; Mohan Liu; Aarohi Bhatt; Zhong Wang; Prachi Nandoskar et al.
Source: check_circle
Crossref

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

Cancer immunology, immunotherapy : CII
2024 | Journal article
DOI: 10.1007/s00262-024-03682-w
Part of ISSN: 0340-7004
Contributors: Massari, Francesco; Santoni, Matteo; Takeshita, Hideki; Okada, Yohei; Tapia, Jose Carlos; Basso, Umberto; Maruzzo, Marco; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe et al.
Source: Self-asserted source
Molina-Cerrillo J

Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

European urology oncology
2024 | Journal article
DOI: 10.1016/j.euo.2024.03.011
Part of ISSN: 2588-9311
Contributors: Massari, Francesco; Mollica, Veronica; Fiala, Ondrej; De Giorgi, Ugo; Kucharz, Jakub; Vitale, Maria Giuseppa; Molina-Cerrillo, Javier; Facchini, Gaetano; Seront, Emmanuel; Lenci, Edoardo et al.
Source: Self-asserted source
Molina-Cerrillo J

Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project

Clinical & experimental metastasis
2024 | Journal article
DOI: 10.1007/s10585-024-10296-0
Part of ISSN: 0262-0898
Contributors: Rizzo, Alessandro; Buti, Sebastiano; Giannatempo, Patrizia; Salah, Samer; Molina-Cerrillo, Javier; Massari, Francesco; Kopp, Ray Manneh; Fiala, Ondřej; Galli, Luca; Myint, Zin W et al.
Source: Self-asserted source
Molina-Cerrillo J

Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

2024 | Other
DOI: 10.21203/rs.3.rs-4125332/v1
Contributors: Santoni, Matteo; Roviello, Giandomenico; Grande, Enrique; Giorgi, Ugo; Fiala, Ondrej; Seront, Emmanuel; Molina-Cerrillo, Javier; Pichler, Renate; Myint, Zin; Kucharz, Jakub et al.
Source: Self-asserted source
Molina-Cerrillo J

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study)

Targeted oncology
2024 | Journal article
DOI: 10.1007/s11523-024-01065-w
Part of ISSN: 1776-2596
Contributors: Fiala, Ondřej; Buti, Sebastiano; Bamias, Aristotelis; Massari, Francesco; Pichler, Renate; Maruzzo, Marco; Grande, Enrique; De Giorgi, Ugo; Molina-Cerrillo, Javier; Seront, Emmanuel et al.
Source: Self-asserted source
Molina-Cerrillo J

Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations

Cancer immunology, immunotherapy : CII
2024 | Journal article
DOI: 10.1007/s00262-024-03719-0
Part of ISSN: 0340-7004
Contributors: Incorvaia, Lorena; Monteiro, Fernando Sabino Marques; Massari, Francesco; Park, Se Hoon; Roviello, Giandomenico; Fiala, Ondřej; Myint, Zin W; Kucharz, Jakub; Molina-Cerrillo, Javier; Santini, Daniele et al.
Source: Self-asserted source
Molina-Cerrillo J

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study

Clinical Genitourinary Cancer
2024-04 | Journal article
DOI: 10.1016/j.clgc.2023.11.013
Contributors: Fernando Sabino Marques Monteiro; Ondřej Fiala; Francesco Massari; Zin W. Myint; Jindrich Kopecky; Jakub Kucharz; Thomas Büttner; Enrique Grande; Maria Teresa Bourlon; Javier Molina-Cerrillo et al.
Source: check_circle
Crossref

Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study

Clinical and experimental medicine
2023 | Journal article
DOI: 10.1007/s10238-023-01235-6
Part of ISSN: 1591-8890
Contributors: Santoni, Matteo; Massari, Francesco; Takeshita, Hideki; Tapia, Jose Carlos; Dionese, Michele; Pichler, Renate; Rizzo, Mimma; Lam, Elaine T; Grande, Enrique; Kemp, Robert et al.
Source: Self-asserted source
Molina-Cerrillo J
grade
Preferred source (of 2)‎

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Clinical genitourinary cancer
2023 | Journal article
DOI: 10.1016/j.clgc.2023.03.006
Part of ISSN: 1558-7673
Contributors: Santoni, Matteo; Massari, Francesco; Myint, Zin W; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Salfi, Alessia et al.
Source: Self-asserted source
Molina-Cerrillo J

Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis

Cancer immunology, immunotherapy : CII
2023 | Journal article
DOI: 10.1007/s00262-022-03349-4
Part of ISSN: 0340-7004
Contributors: Santoni, Matteo; Rizzo, Alessandro; Kucharz, Jakub; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Tassinari, Elisa; Monteiro, Fernando Sabino Marques; Soares, Andrey; Molina-Cerrillo, Javier et al.
Source: Self-asserted source
Molina-Cerrillo J
grade
Preferred source (of 2)‎

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations

Minerva urology and nephrology
2023 | Journal article
DOI: 10.23736/s2724-6051.23.05369-7
Part of ISSN: 2724-6051
Contributors: Porta, Camillo; Bamias, Aristotelis; Zakopoulou, Roubini; Myint, Zin W; Cavasin, Nicolò; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma et al.
Source: Self-asserted source
Molina-Cerrillo J
grade
Preferred source (of 2)‎

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Targeted oncology
2023 | Journal article
DOI: 10.1007/s11523-023-00978-2
Part of ISSN: 1776-2596
Contributors: Santoni, Matteo; Massari, Francesco; Myint, Zin W; Iacovelli, Roberto; Pichler, Martin; Basso, Umberto; Kopecky, Jindrich; Kucharz, Jakub; Buti, Sebastiano; Rizzo, Mimma et al.
Source: Self-asserted source
Molina-Cerrillo J
grade
Preferred source (of 2)‎

Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

Cancer immunology, immunotherapy : CII
2023 | Journal article
DOI: 10.1007/s00262-023-03469-5
Part of ISSN: 0340-7004
Contributors: Santoni, Matteo; Myint, Zin W; Büttner, Thomas; Takeshita, Hideki; Okada, Yohei; Lam, Elaine T; Gilbert, Danielle; Küronya, Zsófia; Tural, Deniz; Pichler, Renate et al.
Source: Self-asserted source
Molina-Cerrillo J

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

European urology oncology
2023 | Journal article
DOI: 10.1016/j.euo.2023.07.003
Part of ISSN: 2588-9311
Contributors: Santoni, Matteo; Buti, Sebastiano; Myint, Zin W; Maruzzo, Marco; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma; Galli, Luca et al.
Source: Self-asserted source
Molina-Cerrillo J

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Cancer immunology, immunotherapy : CII
2023 | Journal article
DOI: 10.1007/s00262-023-03518-z
Part of ISSN: 0340-7004
Contributors: Fiala, Ondřej; Buti, Sebastiano; Takeshita, Hideki; Okada, Yohei; Massari, Francesco; Palacios, Georgia Anguera; Dionese, Michele; Scagliarini, Sarah; Büttner, Thomas; Fornarini, Giuseppe et al.
Source: Self-asserted source
Molina-Cerrillo J

Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas

Actas Urológicas Españolas (English Edition)
2023-03 | Journal article
DOI: 10.1016/j.acuroe.2022.08.008
Part of ISSN: 2173-5786
Contributors: M. Araujo-Castro; E. Pascual-Corrales; J. Lorca Álvaro; C. Mínguez Ojeda; H. Pian; I. Ruz-Caracuel; A. Sanjuanbenito Dehesa; A.B. Serrano Romero; T. Alonso-Gordoa; J. Molina-Cerrillo et al.
Source: Self-asserted source
Molina-Cerrillo J via Crossref Metadata Search

Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences

Cancers
2023-01 | Journal article | Author
DOI: 10.3390/cancers15020408
Contributors: Matteo Santoni; Molina-Cerrillo J; Giorgio Santoni; Elaine T. Lam; Francesco Massari; Veronica Mollica; Giulia Mazzaschi; Bernardo Rapoport; Enrique Grande; Sebastiano Buti
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

Cancers
2022-12 | Journal article | Author
DOI: 10.3390/cancers14246071
Contributors: Javier Pozas; Sara Alvarez Rodríguez; Victor Albarran Fernandez; Javier Burgos; Matteo Santoni; Ray Manneh Kopp; Molina-Cerrillo J; Teresa Alonso-Gordoa
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Epigenetics in advanced renal cell carcinoma: Potential new targets

Critical Reviews in Oncology/Hematology
2022-12 | Journal article
DOI: 10.1016/j.critrevonc.2022.103857
Contributors: Javier Molina-Cerrillo; Matteo Santoni; Álvaro Ruiz; Francesco Massari; Javier Pozas; Ignacio Ortego; Victoria Gómez; Enrique Grande; Teresa Alonso-Gordoa
Source: check_circle
Crossref

Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases

Clinical and Experimental Medicine
2022-08 | Journal article
DOI: 10.1007/s10238-021-00763-3
Contributors: Marta Araujo-Castro; Lía Nattero Chavez; Alberto Martínez Lorca; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Eider Pascual-Corrales
Source: check_circle
Crossref

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study

Cancers
2022-08-26 | Journal article
DOI: 10.3390/cancers14174142
Contributors: Alessandro Rizzo; Veronica Mollica; Andrea Marchetti; Giacomo Nuvola; Matteo Rosellini; Elisa Tassinari; Javier Molina-Cerrillo; Zin W. Myint; Tomas Buchler; Fernando Sabino Marques Monteiro et al.
Source: check_circle
Crossref

Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison

Clinical Genitourinary Cancer
2022-06 | Journal article
DOI: 10.1016/j.clgc.2022.02.003
Contributors: Matteo Santoni; Gaetano Aurilio; Francesco Massari; Enrique Grande; Marc R Matrana; Mimma Rizzo; Ugo De Giorgi; Lorena Incorvaia; Angelo Martignetti; Javier Molina-Cerrillo et al.
Source: check_circle
Crossref

Bronchial Carcinoids: From Molecular Background to Treatment Approach

Cancers
2022-01 | Journal article | Author
DOI: 10.3390/cancers14030520
Contributors: Marta Araujo Castro; Eider Pascual-Corrales; Molina-Cerrillo J; Nicolás Moreno Mata; Teresa Alonso-Gordoa
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

Oncotarget
2022-01-01 | Journal article
DOI: 10.18632/oncotarget.28312
Part of ISSN: 1949-2553
Contributors: Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Alfredo Carrato; Enrique Grande
Source: Self-asserted source
Molina-Cerrillo J via Crossref Metadata Search

Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma

Cancers
2021-11 | Journal article | Author
DOI: 10.3390/cancers13235981
Contributors: Pablo Álvarez Ballesteros; Jesús Chamorro; María San Román-Gil; Javier Pozas; Victoria Gómez Dos Santos; Álvaro Ruiz Granados; Enrique Grande; Teresa Alonso-Gordoa; Molina-Cerrillo J
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance

Biomedicines
2021-03 | Journal article | Author
DOI: 10.3390/biomedicines9030304
Contributors: Marta Araujo Castro; Eider Pascual-Corrales; Molina-Cerrillo J; Teresa Alonso-Gordoa
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia

Healthcare
2021-01 | Journal article | Author
DOI: 10.3390/healthcare9010078
Contributors: Molina-Cerrillo J; Juan Marquet-Palomanes; Teresa Alonso-Gordoa; Javier López-Jiménez; Enrique Grande
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Novel Tyrosine Kinase Targets in Urothelial Carcinoma

International Journal of Molecular Sciences
2021-01 | Journal article | Author
DOI: 10.3390/ijms22020747
Contributors: Javier Torres-Jiménez; Victor Albarran Fernandez; Javier Pozas; María San Román-Gil; Jorge Esteban-Villarrubia; ALFREDO CARRATO; Adriana Rosero Rodríguez; Enrique Grande; Teresa Alonso-Gordoa; Molina-Cerrillo J
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Clinical surveillance in immunotherapy-treated patient,Vigilancia clínica de los pacientes que reciben inmunoterapia

Medicina Clinica
2020 | Journal article
DOI: 10.1016/j.medcli.2020.03.002
EID:

2-s2.0-85083099454

Part of ISBN:

15788989 00257753
Contributors: Molina-Cerrillo, J.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

In Reply

Oncologist
2020 | Journal article
DOI: 10.1634/theoncologist.2020-0336
EID:

2-s2.0-85089218087

Part of ISBN:

1549490X 10837159
Contributors: Grande, E.; Molina-Cerrillo, J.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

Oncologist
2020 | Journal article
DOI: 10.1634/theoncologist.2020-0033
EID:

2-s2.0-85079713933

Part of ISBN:

1549490X 10837159
Contributors: Grande, E.; Teulé, A.; Alonso-Gordoa, T.; Jiménez-Fonseca, P.; Benavent, M.; Capdevila, J.; Custodio, A.; Vera, R.; Munarriz, J.; La Casta, A. et al.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Tyrosine Kinase Receptors in Oncology

International Journal of Molecular Sciences
2020-11-12 | Journal article
DOI: 10.3390/ijms21228529
Contributors: Jorge Esteban-Villarrubia; Juan José Soto-Castillo; Javier Pozas; María San Román-Gil; Inmaculada Orejana-Martín; Javier Torres-Jiménez; Alfredo Carrato; Teresa Alonso-Gordoa; Javier Molina-Cerrillo
Source: check_circle
Crossref

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy

International Journal of Molecular Sciences
2020-07 | Journal article | Author
DOI: 10.3390/ijms21144951
Contributors: María San Román Gil; Javier Pozas; Molina-Cerrillo J; Joaquín Gómez; Héctor Pian; Miguel Pozas; ALFREDO CARRATO; Enrique Grande; Teresa Alonso-Gordoa
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

BRAF Mutated Colorectal Cancer: New Treatment Approaches

Cancers
2020-06 | Journal article | Author
DOI: 10.3390/cancers12061571
Contributors: Molina-Cerrillo J; María San Román; Javier Pozas; Teresa Alonso-Gordoa; Miguel Pozas; Elisa Conde-Moreno; Marta Rosas; Enrique Grande; María Laura García-Bermejo; ALFREDO CARRATO
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

Cardiopulmonary toxicity of antineoplastic drugs,Toxicidad cardiopulmonar de los antineoplásicos

Revisiones en Cancer
2019 | Journal article
EID:

2-s2.0-85072407939

Part of ISBN:

02138573
Contributors: Orejana Martín, I.; Pozas Pérez, J.; San Román Gil, M.; Molina Cerrillo, J.; Alonso Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long-Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor

Oncologist
2019 | Journal article
DOI: 10.1634/theoncologist.2018-0776
EID:

2-s2.0-85062982495

Part of ISBN:

1549490X 10837159
Contributors: Molina-Cerrillo, J.; Grande, E.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?

European Journal of Internal Medicine
2019 | Journal article
DOI: 10.1016/j.ejim.2019.05.020
EID:

2-s2.0-85065915536

Part of ISBN:

18790828 09536205
Contributors: Barquín-García, A.; Molina-Cerrillo, J.; Garrido, P.; Garcia-Palos, D.; Carrato, A.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 3)‎

Phalangeal metastasis in colon adenocarcinoma,Metástasis falángica en adenocarcinoma de colon

Medicina Clinica
2019 | Journal article
DOI: 10.1016/j.medcli.2018.04.012
EID:

2-s2.0-85047437831

Part of ISBN:

15788989 00257753
Contributors: Molina-Cerrillo, J.; Barquin-García, A.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Tumor-associated macrophages: “Good cop-bad cop”

Cancer
2019 | Journal article
DOI: 10.1002/cncr.32016
EID:

2-s2.0-85061473999

Part of ISBN:

10970142 0008543X
Contributors: Molina-Cerrillo, J.; Alonso-Gordoa, T.; Garrido, P.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 3)‎

Undifferentiated paranasal sinus tumors. Experience in the Hospital Universitario Ramón y Cajal: A case report and a literature review,Tumores indiferenciados de senos paranasales. Experiencia del Hospital Universitario Ramón y Cajal a propósito de un caso y revisión de la literatura

Medicina Clinica Practica
2019 | Journal article
DOI: 10.1016/j.mcpsp.2019.02.006
EID:

2-s2.0-85065732356

Part of ISBN:

26039249
Contributors: Molina-Cerrillo, J.; Garrido, P.; Soria, A.; Alonso-Gordoa, T.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms

International Journal of Molecular Sciences
2019-10-08 | Journal article
DOI: 10.3390/ijms20194949
Contributors: Javier Pozas; María San Román; Teresa Alonso-Gordoa; Miguel Pozas; Laura Caracuel; Alfredo Carrato; Javier Molina-Cerrillo
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

Targeting Tyrosine kinases in Renal Cell Carcinoma: “New Bullets against Old Guys”

International Journal of Molecular Sciences
2019-04 | Journal article | Author
DOI: 10.3390/ijms20081901
Contributors: Teresa Alonso-Gordoa; María Laura García-Bermejo; Enrique Grande; Pilar Garrido; Alfredo Carrato; Molina-Cerrillo J
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs

Cancers
2019-03 | Journal article | Author
DOI: 10.3390/cancers11030346
Contributors: Elisa Conde-Moreno; Alejandro Pascual; Daniel Prieto-Cuadra; Val F. Laza; Molina-Cerrillo J; Miren Edurne Ramos-Muñoz; Esperanza Macarena Rodríguez-Serrano; José Luis Soto; Alfredo Carrato; María Laura García-Bermejo et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 4)‎

Prognostic and predictive role of the PI3K–AKT–mTOR pathway in neuroendocrine neoplasms

Clinical and Translational Oncology
2018 | Journal article
DOI: 10.1007/s12094-017-1758-3
EID:

2-s2.0-85033466173

Part of ISBN:

16993055 1699048X
Contributors: Gajate, P.; Alonso-Gordoa, T.; Martínez-Sáez, O.; Molina-Cerrillo, J.; Grande, E.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Bruton's tyrosine kinase (BTK) as a promising target in solid tumors

Cancer Treatment Reviews
2017 | Journal article
DOI: 10.1016/j.ctrv.2017.06.001
EID:

2-s2.0-85020911528

Part of ISBN:

15321967 03057372
Contributors: Molina-Cerrillo, J.; Alonso-Gordoa, T.; Gajate, P.; Grande, E.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy

Critical Reviews in Oncology/Hematology
2017 | Journal article
DOI: 10.1016/j.critrevonc.2017.01.013
EID:

2-s2.0-85014112685

Part of ISBN:

18790461 10408428
Contributors: Martínez-Sáez, O.; Gajate Borau, P.; Alonso-Gordoa, T.; Molina-Cerrillo, J.; Grande, E.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Inhibition of peripheral synthesis of serotonin as a new target in neuroendocrine tumors

Oncologist
2016 | Journal article
DOI: 10.1634/theoncologist.2015-0455
EID:

2-s2.0-84975297945

Part of ISBN:

1549490X 10837159
Contributors: Molina-Cerrillo, J.; Alonso-Gordoa, T.; Martínez-Sáez, O.; Grande, E.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

Primary sarcomatoid tumor of the bladder: A different entity but the same approach?

Clinical Genitourinary Cancer
2015 | Journal article
DOI: 10.1016/j.clgc.2015.05.001
EID:

2-s2.0-84947870824

Part of ISBN:

19380682 15587673
Contributors: Molina-Cerrillo, J.; Martínez-Sáez, O.; Alonso-Gordoa, T.; Tirado-Zambrano, P.; Delgado-Vargas, B.; Earl, J.; Grande, E.
Source: Self-asserted source
Molina-Cerrillo J via Scopus - Elsevier
grade
Preferred source (of 2)‎

2408TiP DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints

Annals of Oncology
Journal article
DOI: 10.1016/j.annonc.2023.09.2826
Source: Self-asserted source
Molina-Cerrillo J via Crossref Metadata Search
Items per page:
Page 1 of 2

Peer review (11 reviews for 9 publications/grants)

Review activity for Biochimica et biophysica acta (2)
Review activity for Biomedicines. (2)
Review activity for Cell death discovery. (1)
Review activity for Current oncology. (1)
Review activity for Diagnostics. (1)
Review activity for International journal of molecular sciences. (1)
Review activity for Medicina. (1)
Review activity for Pharmaceuticals. (1)
Review activity for The Lancet regional health. (1)
How many people are using ORCID?